Search
Researchers learn how prostate cancer cells change their type to survive treatment.
By identifying mutations found in a person’s cancer, this blood test can help doctors tailor treatments to those most likely to benefit.
Scientists have uncovered new information about what orchestrates the complex balance between blood stem cells and mature blood cells, a relationship that is often disrupted in leukemia. The results will lead to a better understanding of the behavior of leukemic cells and may have vital clinical applications for patients recovering from chemotherapy, radiation therapy, or bone marrow transplantation.
Get to know Ashley Chui, a chemical biology graduate student in the Sloan Kettering Institute.
Joan Argetsinger Steitz, PhD, Sterling Professor of Molecular Biophysics and Biochemistry at Yale School of Medicine, will also be honored with the 2021 Honorary Degree and the MSK Medal for Outstanding Contributions to Biomedical Research.
A low-dose radiation approach could help more patients avoid side effects of treatment for head and neck cancer.
Several MSK physicians and researchers presenting during the plenary sessions.
A surprising discovery linking the hormone insulin to skin pigmentation offers fresh insights into how animal bodies take shape.
Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.